Foresite Capital Fund II, L.P., 10% Owner at Aimmune Therapeutics, Inc. (AIMT), bought 25,485 shares at $19.65 ($501K) on 2015-08-24, disclosed to the SEC on 2015-08-26.
Open-market purchase of $501k AIMT by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |